On November 4th, Gelonhui announced that Sailong Pharmaceutical Group (002898.SZ) recently received a "Notice of Change in Equity Ratio Reaching 1%" issued by Zhuhai Hengqin New Area Sailong Juzhi Investment Co., Ltd., a shareholder holding more than 5% of the shares. It was learned that since the company's previous disclosure of the "Announcement of Shareholder reducing their shareholding by more than 1%", Sailong Juzhi reduced its holdings through centralized auction trading from November 26, 2022, to November 28, 2022, by 130,000 shares, from May 4, 2023, to June 2, 2023, by 279,500 shares, and from September 10, 2024, to November 4, 2024, by 1,350,500 shares, totaling 1% of the company's total share capital.
赛隆药业(002898.SZ)：赛隆聚智累计减持1%股份
Sailong Pharmaceutical Group (002898.SZ): Sailong Polyintelligence has cumulatively decreased its shareholding by 1%.
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Hot News
Updated